Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons

References

• Influenza vaccines. Wkly Epidemiol Rec 2005; 80:279 - 87; PMID: 16171031
   PubMedGoogle Scholar
• Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008; 57:RR-7 1 - 60; PMID: 18685555
   PubMedGoogle Scholar
• Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009; 27:5043 - 53; http://dx.doi.org/10.1016/j.vaccine.2009.06.032; PMID: 19559118
   PubMed Web of Science ®Google Scholar
• Bridges CB, Katz JM, Levandowski RA and NJ C. Inactivated influenza vaccines. 5 ed. Philadelphia: Saunders, 2008 (Plotkin SA, Orenstein WA and PA O, eds. Vaccines)
   Google Scholar
• Ulmer JB, Valley U, Rappuoli R. Vaccine manufacturing: challenges and solutions. Nat Biotechnol 2006; 24:1377 - 83; http://dx.doi.org/10.1038/nbt1261; PMID: 17093488
   PubMed Web of Science ®Google Scholar
• Wright PF. Vaccine preparedness--are we ready for the next influenza pandemic?. N Engl J Med 2008; 358:2540 - 3; http://dx.doi.org/10.1056/NEJMp0803650; PMID: 18550873
   PubMed Web of Science ®Google Scholar
• Mabrouk T, Ellis RW. Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine). Dev Biol (Basel) 2002; 110:125 - 34; PMID: 12477315
   PubMedGoogle Scholar
• (WHO) WHO. Influenza. Fact sheet No. 211. 2003. Available at: http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed 5 august 2010.
   Google Scholar
• Belshe RB. Translational research on vaccines: influenza as an example. Clin Pharmacol Ther 2007; 82:745 - 9; http://dx.doi.org/10.1038/sj.clpt.6100419; PMID: 17971813
   PubMed Web of Science ®Google Scholar
• Halperin SA, Smith B, Mabrouk T, Germain M, Trépanier P, Hassell T, et al. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine 2002; 20:1240 - 7; http://dx.doi.org/10.1016/S0264-410X(01)00428-5; PMID: 11803087
   PubMed Web of Science ®Google Scholar
• Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Dorner F. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 1998; 16:960 - 8; http://dx.doi.org/10.1016/S0264-410X(97)00301-0; PMID: 9682344
   PubMed Web of Science ®Google Scholar
• Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18:64 - 76; PMID: 8877331
   PubMed Web of Science ®Google Scholar
• Ambrozaitis A, Groth N, Bugarini R, Sparacio V, Podda A, Lattanzi M. A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine. Vaccine 2009; 27:6022 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.07.083; PMID: 19666152
   PubMed Web of Science ®Google Scholar
• Doroshenko A, Halperin SA. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert Rev Vaccines 2009; 8:679 - 88; http://dx.doi.org/10.1586/erv.09.31; PMID: 19485748
   PubMed Web of Science ®Google Scholar
• Groth N, Montomoli E, Gentile C, Manini I, Bugarini R, Podda A. Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial. Vaccine 2009; 27:786 - 91; http://dx.doi.org/10.1016/j.vaccine.2008.11.003; PMID: 19027046
   PubMed Web of Science ®Google Scholar
• Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. J Infect Dis 2009; 200:849 - 57; http://dx.doi.org/10.1086/605506; PMID: 19673652
   PubMed Web of Science ®Google Scholar
• Szymczakiewicz-Multanowska A, Groth N, Bugarini R, Lattanzi M, Casula D, Hilbert A, et al. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. J Infect Dis 2009; 200:841 - 8; http://dx.doi.org/10.1086/605505; PMID: 19673651
   PubMed Web of Science ®Google Scholar
• Frey S, Vesikari T, Szymczakiewicz-Multanowska A, Lattanzi M, Izu A, Groth N, et al. Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51:997 - 1004; http://dx.doi.org/10.1086/656578; PMID: 20868284
   PubMed Web of Science ®Google Scholar
• Keitel W, Groth N, Lattanzi M, Praus M, Hilbert AK, Borkowski A, et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. Vaccine 2010; 28:840 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.10.019; PMID: 19835829
   PubMed Web of Science ®Google Scholar
• Perucchini E, Consonni S, Sandrini MC, Bergamaschini L, Vergani C. Adverse reactions to influenza vaccine alone or with pneumococcal vaccine in the elderly. [No abstract available.] J Am Geriatr Soc 2004; 52:1219 - 20; http://dx.doi.org/10.1111/j.1532-5415.2004.52327_5.x; PMID: 15209671
   PubMed Web of Science ®Google Scholar
• Grilli G, Fuiano L, Biasio LR, Pregliasco F, Plebani A, Leibovitz M, et al. Simultaneous influenza and pneumococcal vaccination in elderly individuals. Eur J Epidemiol 1997; 13:287 - 91; http://dx.doi.org/10.1023/A:1007398606807; PMID: 9258527
   PubMed Web of Science ®Google Scholar
• De Stefano F, Richard A, Goodman MD, et al. Simultaneous Administration of influenza and pneumococcal vaccines. JAMA 1982; 247:2551 - 2554; http://dx.doi.org/10.1001/jama.1982.03320430055032
   Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. 12 March, 1997. Available at http://www.emea.europa.eu/pdfs/human/bwp/021496en.pdf. Accessed 5 august 2010.
   Google Scholar